Selective Ligands of Human Constitutive Androstane Receptor
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11160%2F24%3A10486751" target="_blank" >RIV/00216208:11160/24:10486751 - isvavai.cz</a>
Alternative codes found
RIV/61388963:_____/24:00604905
Result on the web
<a href="http://worldwide.espacenet.com/publicationDetails/biblio?FT=D&CC=EP&NR=3962915B1" target="_blank" >http://worldwide.espacenet.com/publicationDetails/biblio?FT=D&CC=EP&NR=3962915B1</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Selective Ligands of Human Constitutive Androstane Receptor
Original language description
The present invention provides a structurally novel class of heterocyclic compounds of general formula I wherein L1 is heteroaryl and L2 is heteroaryl or aryl. The novel compounds are useful in a method of prevention or treatment of a condition which is mediated by the action, or by loss of action, of Constitutive androstane receptor (CAR) receptor or its endogenous ligands. The present invention thus provides the novel compounds for medicinal use, as well as pharmaceutical composition containing said compounds. (I)
Czech name
—
Czech description
—
Classification
Type
P - Patent
CEP classification
—
OECD FORD branch
30104 - Pharmacology and pharmacy
Result continuities
Project
<a href="/en/project/TN01000013" target="_blank" >TN01000013: Personalized Medicine – Diagnostics and Therapy</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2024
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Patent/design ID
EP3962915
Publisher
EPO_1 -
Publisher name
European Patent Office
Place of publication
Munich, The Hague, Berlin, Vienna, Brussels
Publication country
—
Date of acceptance
Sep 4, 2024
Owner name
ÚOCHB AVČR ; Univerzita Karlova
Method of use
B - Výsledek je využíván orgány státní nebo veřejné správy
Usage type
A - K využití výsledku jiným subjektem je vždy nutné nabytí licence